Gainers
- FIGS (NYSE:FIGS) stock rose 11.1% to $15.6 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 149.2K shares, which is 5.1 percent of its average volume over the last 100 days. The company's market cap stands at $2.5 billion. As per the news, the Q4 earnings report came out today.
- Purple Biotech (NASDAQ:PPBT) shares rose 9.02% to $2.9. The market value of their outstanding shares is at $51.6 million.
- Assertio Holdings (NASDAQ:ASRT) stock rose 7.79% to $2.35. The company's market cap stands at $104.8 million.
- Statera BioPharma (NASDAQ:STAB) stock increased by 6.89% to $0.62. This security traded at a volume of 121.6K shares come close, making up 21.3% of its average volume over the last 100 days. The company's market cap stands at $22.2 million.
- Renalytix (NASDAQ:RNLX) stock rose 6.36% to $7.85. The market value of their outstanding shares is at $283.8 million.
- Landos Biopharma (NASDAQ:LABP) stock rose 5.44% to $1.55. The company's market cap stands at $62.3 million.
Losers
- Ontrak (NASDAQ:OTRK) shares fell 23.6% to $1.94 during Tuesday's after-market session. Trading volume for this security closed at 136.5K, accounting for 31.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.1 million. As per the news, the Q4 earnings report came out today.
- CytoSorbents (NASDAQ:CTSO) stock fell 10.43% to $3.35. The company's market cap stands at $145.6 million. The company's, Q4 earnings came out today.
- Kala Pharmaceuticals (NASDAQ:KALA) shares fell 5.22% to $1.09. This security traded at a volume of 297.0K shares come close, making up 37.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $78.8 million.
- SCWorx (NASDAQ:WORX) shares decreased by 5.0% to $0.72. The market value of their outstanding shares is at $8.1 million.
- Abeona Therapeutics (NASDAQ:ABEO) stock fell 5.0% to $0.28. At the close, Abeona Therapeutics's trading volume reached 137.2K shares. This is 3.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $40.3 million.
- Xenetic Biosciences (NASDAQ:XBIO) stock declined by 4.86% to $0.85. The company's market cap stands at $11.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
